¹⁸F-fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine

Lancet. 2021 Mar 20;397(10279):e9. doi: 10.1016/S0140-6736(21)00464-5. Epub 2021 Mar 8.

Authors

Julie Steinberg¹, Alex Thomas², Amir Iravani³

Affiliations

¹ Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis MO, USA. Electronic address: juliesteinberg@wustl.edu.
² University School of Medicine, Washington University in St Louis, St Louis MO, USA.
³ Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis MO, USA.

No abstract available

Publication types

Case Reports
Video-Audio Media

MeSH terms

2019-nCoV Vaccine mRNA-1273
Aged
COVID-19 / diagnosis
COVID-19 / immunology
COVID-19 / prevention & control*
COVID-19 / virology
COVID-19 Nucleic Acid Testing
COVID-19 Vaccines / adverse effects*
Diagnosis, Differential
Female
Fluorodeoxyglucose F18 / administration & dosage
Humans
Lymph Nodes / diagnostic imaging
Lymph Nodes / immunology
Positron Emission Tomography Computed Tomography
SARS-CoV-2 / immunology*
SARS-CoV-2 / isolation & purification
Spleen / diagnostic imaging
Spleen / immunology
Systemic Inflammatory Response Syndrome / diagnosis*
Systemic Inflammatory Response Syndrome / immunology

Substances

COVID-19 Vaccines
Fluorodeoxyglucose F18
2019-nCoV Vaccine mRNA-1273